Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Stock price declined due to uncertainty around drug price controls, tariffs, and budget cuts. Contract Research Organization...
— Tony Coniaris
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on IQVIA Holdings Inc.
IQVIA Holdings ($IQV), representing 6.9% of the fund's assets, is a leading provider of data analytics, technology solutions, and outsourced clinical research services to the life sciences and healthcare industries. The manager maintains...
IQVIA Holdings ($IQV), representing 3.3% of the fund's net assets, is a leading global provider of advanced data analytics, clinical research services, and technology infrastructure to life sciences and biopharmaceutical enterprises. The manager holds...
IQVIA Holdings ($IQV) is a global leader in clinical research outsourcing, advanced healthcare analytics, and pharmaceutical commercial intelligence. Broyhill holds a...
More institutional theses from Harris Associates Concentrated Strategy
SAP is one of the largest enterprise software providers in the world and a global leader in enterprise resource planning.
LVMH was a detractor during the quarter. The France headquartered...
Unicharm is a leading global personal care company, best known for products across feminine hygiene, adult incontinence, and baby diapers.